Ignyte Acquisition Corp. Unit
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch IGNYU and buy or sell other stocks, ETFs, and their options commission-free!About IGNYU
Peak Bio Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of commercialization of therapeutics that aim to address the medical need of patients with inflammatory, rare and specialty diseases, and cancer. It focuses on the development of treatment of alpha-1 antitrypsin (AAT) deficiency (AATD), a genetic disorder that may result in lung disease or liver disease.
CEOStephen J. LaMond, PhD, MBA
CEOStephen J. LaMond, PhD, MBA
Employees—
Employees—
HeadquartersPleasanton, California
HeadquartersPleasanton, California
Founded2016
Founded2016
Employees—
Employees—
IGNYU Key Statistics
Market cap94.45M
Market cap94.45M
Price-Earnings ratio-136.71
Price-Earnings ratio-136.71
Dividend yield—
Dividend yield—
Average volume3.98K
Average volume3.98K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$13.00
52 Week high$13.00
52 Week low$9.50
52 Week low$9.50
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.